✦ LIBER ✦

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non-Small-Cell Lung Cancer

✍ Scribed by Herbst, R. S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TRIBUTE: A Phase III Trial of Erlotinib

✍ Herbst, R. S. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 304 KB

Select Clinical Trials of Erlotinib (OSI

✍ L. Minerva Burgos Fuster; Alan B. Sandler 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 330 KB

Erlotinib (OSI-774, Tarceva™), a Selecti

✍ Mary Hightower; Chandra P. Belani; Vinay K. Jain 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 78 KB

Paclitaxel and carboplatin in combinatio

✍ Ceresoli, G.L; Favaretto, A; Paccagnella, A; Barbieri, F; Bearz, A; Schiavon, A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Phase II trial of carboplatin and paclit

✍ Yoh, Kiyotaka; Kubota, Kaoru; Kakinuma, Ryutaro; Ohmatsu, Hironobu; Goto, Koichi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 139 KB

O-082 A randomized phase III trial compa

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB